Corvus Pharmaceuticals Inc (CRVS)
5.00
-0.09
(-1.77%)
USD |
NASDAQ |
Dec 20, 16:00
5.00
0.00 (0.00%)
After-Hours: 20:00
Corvus Pharmaceuticals Shareholders Equity (Quarterly): 12.41M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 328.47M |
| Sarepta Therapeutics Inc | 1.221B |
| Cara Therapeutics Inc | 0.707M |
| Atara Biotherapeutics Inc | -90.54M |
| Clearside Biomedical Inc | -34.79M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 58.82M |
| Total Liabilities (Quarterly) | 46.41M |